Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
about
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Docetaxel and Cyclophosphamide ...... th HER2-Negative Breast Cancer
@en
type
label
Docetaxel and Cyclophosphamide ...... th HER2-Negative Breast Cancer
@en
prefLabel
Docetaxel and Cyclophosphamide ...... th HER2-Negative Breast Cancer
@en
P4844
P6153
P1132
P131
P1476
A Phase III Clinical Trial Com ...... e, HER2-Negative Breast Cancer
@en
P3098
NCT01547741
P580
2012-04-01T00:00:00Z
P582
2019-12-01T00:00:00Z